BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 24113572)

  • 1. Survival after lung transplantation in systemic sclerosis. A systematic review.
    Khan IY; Singer LG; de Perrot M; Granton JT; Keshavjee S; Chau C; Kron A; Johnson SR
    Respir Med; 2013 Dec; 107(12):2081-7. PubMed ID: 24113572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study.
    Bernstein EJ; Peterson ER; Sell JL; D'Ovidio F; Arcasoy SM; Bathon JM; Lederer DJ
    Arthritis Rheumatol; 2015 May; 67(5):1314-22. PubMed ID: 25581250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung transplantation in patients with scleroderma.
    De Cruz S; Ross D
    Curr Opin Rheumatol; 2013 Nov; 25(6):714-8. PubMed ID: 24061075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.
    Young A; Vummidi D; Visovatti S; Homer K; Wilhalme H; White ES; Flaherty K; McLaughlin V; Khanna D
    Arthritis Rheumatol; 2019 Aug; 71(8):1339-1349. PubMed ID: 30762947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
    Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
    Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
    Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
    Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation in systemic sclerosis: A single center cohort study.
    Fernández-Codina A; Berastegui C; Pinal-Fernández I; Silveira MG; López-Meseguer M; Monforte V; Guillén-Del Castillo A; Simeón-Aznar CP; Fonollosa-Plà V; Solé J; Bravo-Masgoret C; Román-Broto A
    Joint Bone Spine; 2018 Jan; 85(1):79-84. PubMed ID: 28408277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
    Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
    J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in systemic sclerosis-related lung disease after lung transplantation.
    Sottile PD; Iturbe D; Katsumoto TR; Connolly MK; Collard HR; Leard LA; Hays S; Golden JA; Hoopes C; Kukreja J; Singer JP
    Transplantation; 2013 Apr; 95(7):975-80. PubMed ID: 23545509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
    Ooi C; Solanki K; Lao C; Frampton C; White D
    Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.
    Miele CH; Schwab K; Saggar R; Duffy E; Elashoff D; Tseng CH; Weigt S; Charan D; Abtin F; Johannes J; Derhovanessian A; Conklin J; Ghassemi K; Khanna D; Siddiqui O; Ardehali A; Hunter C; Kwon M; Biniwale R; Lo M; Volkmann E; Torres Barba D; Belperio JA; Sayah D; Mahrer T; Furst DE; Kafaja S; Clements P; Shino M; Gregson A; Kubak B; Lynch JP; Ross D; Saggar R
    Ann Am Thorac Soc; 2016 Jun; 13(6):793-802. PubMed ID: 27078625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary survival study in 91 patients with systemic sclerosis.
    Poormoghim H; Lakeh MM; Mohammadipour M; Talehy-Moineddin S; Sodagari F
    Rheumatol Int; 2011 Dec; 31(12):1577-82. PubMed ID: 20496069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation.
    Yazdani A; Singer LG; Strand V; Gelber AC; Williams L; Mittoo S
    J Heart Lung Transplant; 2014 May; 33(5):514-20. PubMed ID: 24630861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.